HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.

AbstractOBJECTIVES:
The term ´Rasopathies´ represents a group of five neurodevelopmental syndromes (Noonan, LEOPARD, Costello, Cardio-facio-cutaneous, and Neurofibromatose-Noonan syndrome) caused by germline mutation in genes encoding proteins involved in RAS/MAPK (rat sarcoma/mitogen-activated protein kinase) signaling pathway. The RAS/MAPK signaling pathway participates in regulation of cell determination, proliferation, differentiation, migration, and senescence and dysregulation of this pathway can lead to the risk of tumorigenesis. In this review, we aim to summarize the current clinical and molecular genetic knowledge on Rasopathies with special attention for the risk of cancer. We propose also clinical and therapeutic approach for patients with malignancy.
METHODS:
We are reviewing the clinical and molecular basis of Rasopathies based on recent studies, clinical examination, and molecular diagnostics (mutation analysis of causal genes for Rasopathies) in Slovak pediatric patients.
RESULTS:
Some clinical features, such as short stature, a specific facial dysmorphology and cardiac abnormalities are common to all of Rasopathy syndromes. However, there are unique signs by which the syndromes can differ from each other, especially multiple lentigo in LEOPARD syndrome, increased risk of malignancy in Costello syndrome, dry hyperkeratotic skin in patients with cardio-facio-cutaneous syndrome, and neurofibromas and cafe-au-lait spots in neurofibromatosis-Noonan syndrome.
CONCLUSION:
Despite the overlapping clinical features, Rasopathy syndromes exhibit unique fenotypical features and the precise molecular diagnostics may lead to confirmation of each syndrome. The molecular diagnostics may allow the detection of pathogenic mutation associated with tumorigenesis.
AuthorsM Cizmarova, L Kostalova, Z Pribilincova, Z Lasabova, A Hlavata, L Kovacs, D Ilencikova
JournalEndocrine regulations (Endocr Regul) Vol. 47 Issue 4 Pg. 217-22 (Oct 2013) ISSN: 1210-0668 [Print] Germany
PMID24156711 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • ras Proteins
Topics
  • Body Height (genetics)
  • Costello Syndrome (epidemiology, genetics, metabolism)
  • Ectodermal Dysplasia (epidemiology, genetics, metabolism)
  • Facies
  • Failure to Thrive (epidemiology, genetics, metabolism)
  • Heart Defects, Congenital (epidemiology, genetics, metabolism)
  • Humans
  • MAP Kinase Signaling System (genetics)
  • Neoplasms (epidemiology, genetics, metabolism)
  • Neurofibromatoses (epidemiology, genetics, metabolism)
  • Noonan Syndrome (epidemiology, genetics, metabolism)
  • Risk Factors
  • ras Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: